PT1948237E - Utilização de β-1,3(4)-endoglucano-hidrolase, β-1,3(4)- glucano, terra diatomácea, argila mineral e glucomanano para aumentar a função imunitária - Google Patents

Utilização de β-1,3(4)-endoglucano-hidrolase, β-1,3(4)- glucano, terra diatomácea, argila mineral e glucomanano para aumentar a função imunitária Download PDF

Info

Publication number
PT1948237E
PT1948237E PT05784461T PT05784461T PT1948237E PT 1948237 E PT1948237 E PT 1948237E PT 05784461 T PT05784461 T PT 05784461T PT 05784461 T PT05784461 T PT 05784461T PT 1948237 E PT1948237 E PT 1948237E
Authority
PT
Portugal
Prior art keywords
immune function
endoglucanohydrolase
glucomannan
glucan
diatomaceous earth
Prior art date
Application number
PT05784461T
Other languages
English (en)
Inventor
Omnigen Research Llc
Original Assignee
Omnigen Research Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omnigen Research Llc filed Critical Omnigen Research Llc
Publication of PT1948237E publication Critical patent/PT1948237E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
PT05784461T 2005-08-10 2005-08-10 Utilização de β-1,3(4)-endoglucano-hidrolase, β-1,3(4)- glucano, terra diatomácea, argila mineral e glucomanano para aumentar a função imunitária PT1948237E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/028529 WO2007021262A1 (en) 2005-08-10 2005-08-10 USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION

Publications (1)

Publication Number Publication Date
PT1948237E true PT1948237E (pt) 2011-07-05

Family

ID=35455890

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05784461T PT1948237E (pt) 2005-08-10 2005-08-10 Utilização de β-1,3(4)-endoglucano-hidrolase, β-1,3(4)- glucano, terra diatomácea, argila mineral e glucomanano para aumentar a função imunitária

Country Status (12)

Country Link
EP (1) EP1948237B8 (pt)
AT (1) ATE507842T1 (pt)
BR (1) BRPI0520481B1 (pt)
CA (1) CA2619219C (pt)
DE (1) DE602005027915D1 (pt)
DK (1) DK1948237T3 (pt)
ES (1) ES2362192T3 (pt)
IL (1) IL189400A (pt)
PL (1) PL1948237T3 (pt)
PT (1) PT1948237E (pt)
SI (1) SI1948237T1 (pt)
WO (1) WO2007021262A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011007550A (es) * 2009-01-14 2011-10-28 Alltech Inc Composiciones de levadura entrelazadas con arcilla y metodos de utilizarlas.
US8318475B2 (en) 2009-01-14 2012-11-27 Alltech, Inc. Clay interlaced yeast compositions and methods of utilizing the same
AU2011201420B2 (en) * 2011-03-29 2015-08-13 Omnigen Research Llc Beta-1,3(4)-endoglucanohydrolase, beta-1,3(4) glucan, diatomaceous earth, mineral clay and glucomannan to modulate gastrointestinal genes
PL3110437T3 (pl) 2014-02-12 2018-04-30 Omnigen Research, Llc Kompozycja i sposób wspomagania obniżania poziomu stresu cieplnego u zwierząt
EP3200608A1 (en) * 2014-10-01 2017-08-09 Omnigen Research, LLC Compositions and combinations for use as food supplements for animals
WO2017044832A1 (en) 2015-09-09 2017-03-16 Omnigen Research, Llc A composition and/or combination for aquaculture
WO2018140450A1 (en) * 2017-01-24 2018-08-02 Costigan Timothy E Granulated feed supplement and methods for making and using
CN112587535B (zh) * 2021-01-06 2024-06-21 澳门大学 葡甘寡糖系列组合物、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300692B1 (no) * 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
RU2093162C1 (ru) * 1995-07-19 1997-10-20 Институт биохимии СО РАН Средство с иммуностимулирующим действием
RU2115421C1 (ru) * 1995-12-25 1998-07-20 Комиссарова Надежда Александровна Фармацевтическая композиция, обладающая иммуномодулирующим и гиполипидемическим действием
WO1999058650A1 (en) * 1998-05-13 1999-11-18 Biomarin Pharmaceuticals Lytic enzymes useful for treating fungal infections

Also Published As

Publication number Publication date
WO2007021262A1 (en) 2007-02-22
DK1948237T3 (da) 2011-08-15
PL1948237T3 (pl) 2012-04-30
IL189400A (en) 2013-05-30
SI1948237T1 (sl) 2011-07-29
BRPI0520481B1 (pt) 2020-11-10
CA2619219C (en) 2013-07-02
IL189400A0 (en) 2008-06-05
EP1948237B8 (en) 2012-02-22
CA2619219A1 (en) 2007-02-22
ES2362192T3 (es) 2011-06-29
EP1948237A1 (en) 2008-07-30
DE602005027915D1 (de) 2011-06-16
EP1948237B1 (en) 2011-05-04
ATE507842T1 (de) 2011-05-15
BRPI0520481A2 (pt) 2010-07-06

Similar Documents

Publication Publication Date Title
IL189400A0 (en) Use of ??-1,3(4)-endoglucanohydrolase, ??-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
WO2022155530A8 (en) Variant strain-based coronavirus vaccines
MY147493A (en) Fibrous materials and compositions
EP1926389B8 (en) Low ph aerated products
WO2008153655A3 (en) Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic fhv-1 infections, and preventing or treating conjunctivitis
NZ583686A (en) Combinations comprising a fungicidal bacillus strain and an carboxamide
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
WO2007039313A3 (en) Probiotic enterococci for improved immunity
PL1841332T3 (pl) Kompozycja zagęszczacza dla pacjentów z trudnością połykania
MX2009007763A (es) Mousse.
TW200727791A (en) Materials and methods for improving livestock productivity
MY148286A (en) Freeze-dried, aerated dairy or dairy-substitute compositions and methods of making thereof
RS50832B (sr) Agens oleogela sa sadržajem triterpena, oleogel sa sadržajem triterpena i postupak za proizvodnju oleogela sa sadržajem triterpena
PT1965809E (pt) Composições para melhorar a saúde do intestino e o rendimento animal compreendendo beta-glucanos e alfa-fucanos
MX2009012010A (es) Composiciones de vegetal o fruta aireadas, liofilizadas y metodos para elaboracion de las mismas.
MY139162A (en) Novolak resins and rubber compositions comprising the same
WO2006078975A3 (en) Improved vaccine against feline calicivirus
CL2011000941A1 (es) Composicion adecuada para la administracion oral a un animal que comprende una enzima reductora del estres inmunologico alfa-mananasa; y su uso para mejorar el rendimiento del crecimiento del animal y/o reducir el estres inmunologico del mismo (div. sol. n°3527-06).
WO2006102216A3 (en) Corn fiber hulls as a food additive or animal feed
WO2008051862A3 (en) Immunopotentiating compositions comprising beta-1,3/1,6-d-glucan and uses thereof
WO2008059041A3 (en) Complementation of factor xi deficiency by factor v mutants
AR043869A1 (es) Un producto alimenticio que comprende almidon y es ambientalmente estable
WO2007008546A3 (en) High tryptophan soybean meal
EP1880727A3 (en) Topical vaginal pharmaceutical compositions
SG165363A1 (en) Conductive hydrocarbon fluid